| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.004 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |